Two-dimensional nanomaterials in cancer theranostics

Jiuhai Wang; Mo Yang

doi:10.1016/B978-0-12-815341-3.00011-0

Two-dimensional nanomaterials in cancer theranostics

Jiuhai Wang
, Mo Yang

Research output: Chapter in book / Conference proceeding › Chapter in an edited book (as author) › Academic research › peer-review

19 Citations (Scopus)

Abstract

In the past decade, two-dimensional (2D) nanomaterials have been used for cancer theranostics including graphene oxide, graphene quantum dot, graphitic carbon nitride nanosheets (g-C₃N₄), black phosphorus (BP), transition metal dichalcogenides (e.g., MoS₂, MnO₂, and WS₂), and metal-organic frameworks (MOFs). Due to their remarkable properties such as large surface-to-volume ratio, tunable energy band, photoluminescence, high drug loading efficiency, and excellent biocompatibility, these 2D nanomaterial-based nanoplatforms have shown great potential for cancer theranostics. This chapter summarizes the recent development of 2D nanomaterial-based theranostic platforms for tumor therapy.

Original language	English
Title of host publication	Theranostic Bionanomaterials
Publisher	Elsevier
Pages	263-288
Number of pages	26
ISBN (Electronic)	9780128153413
ISBN (Print)	9780128153420
DOIs	https://doi.org/10.1016/B978-0-12-815341-3.00011-0
Publication status	Published - 1 Jan 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

2d nanomaterials
Drug release
Theranostics
Tumor therapy

ASJC Scopus subject areas

General Medicine
General Biochemistry,Genetics and Molecular Biology

More information

10.1016/B978-0-12-815341-3.00011-0

Cite this

@inbook{4afe52f270a24396a2d2b568eb5eb897,

title = "Two-dimensional nanomaterials in cancer theranostics",

abstract = "In the past decade, two-dimensional (2D) nanomaterials have been used for cancer theranostics including graphene oxide, graphene quantum dot, graphitic carbon nitride nanosheets (g-C3N4), black phosphorus (BP), transition metal dichalcogenides (e.g., MoS2, MnO2, and WS2), and metal-organic frameworks (MOFs). Due to their remarkable properties such as large surface-to-volume ratio, tunable energy band, photoluminescence, high drug loading efficiency, and excellent biocompatibility, these 2D nanomaterial-based nanoplatforms have shown great potential for cancer theranostics. This chapter summarizes the recent development of 2D nanomaterial-based theranostic platforms for tumor therapy.",

keywords = "2d nanomaterials, Drug release, Theranostics, Tumor therapy",

author = "Jiuhai Wang and Mo Yang",

year = "2019",

month = jan,

day = "1",

doi = "10.1016/B978-0-12-815341-3.00011-0",

language = "English",

isbn = "9780128153420",

pages = "263--288",

booktitle = "Theranostic Bionanomaterials",

publisher = "Elsevier",

address = "Netherlands",

}

TY - CHAP

T1 - Two-dimensional nanomaterials in cancer theranostics

AU - Wang, Jiuhai

AU - Yang, Mo

PY - 2019/1/1

Y1 - 2019/1/1

N2 - In the past decade, two-dimensional (2D) nanomaterials have been used for cancer theranostics including graphene oxide, graphene quantum dot, graphitic carbon nitride nanosheets (g-C3N4), black phosphorus (BP), transition metal dichalcogenides (e.g., MoS2, MnO2, and WS2), and metal-organic frameworks (MOFs). Due to their remarkable properties such as large surface-to-volume ratio, tunable energy band, photoluminescence, high drug loading efficiency, and excellent biocompatibility, these 2D nanomaterial-based nanoplatforms have shown great potential for cancer theranostics. This chapter summarizes the recent development of 2D nanomaterial-based theranostic platforms for tumor therapy.

AB - In the past decade, two-dimensional (2D) nanomaterials have been used for cancer theranostics including graphene oxide, graphene quantum dot, graphitic carbon nitride nanosheets (g-C3N4), black phosphorus (BP), transition metal dichalcogenides (e.g., MoS2, MnO2, and WS2), and metal-organic frameworks (MOFs). Due to their remarkable properties such as large surface-to-volume ratio, tunable energy band, photoluminescence, high drug loading efficiency, and excellent biocompatibility, these 2D nanomaterial-based nanoplatforms have shown great potential for cancer theranostics. This chapter summarizes the recent development of 2D nanomaterial-based theranostic platforms for tumor therapy.

KW - 2d nanomaterials

KW - Drug release

KW - Theranostics

KW - Tumor therapy

UR - https://www.scopus.com/pages/publications/85082621655

U2 - 10.1016/B978-0-12-815341-3.00011-0

DO - 10.1016/B978-0-12-815341-3.00011-0

M3 - Chapter in an edited book (as author)

AN - SCOPUS:85082621655

SN - 9780128153420

SP - 263

EP - 288

BT - Theranostic Bionanomaterials

PB - Elsevier

ER -

Two-dimensional nanomaterials in cancer theranostics

Abstract

UN SDGs

Keywords

ASJC Scopus subject areas

More information

Other files and links

Fingerprint

Cite this